A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA-Reference-Cited by-同舟云学术

A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA

Published:2022-05 Issue: Volume:345 Page:354-370
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Carson Carcia S.,Becker Kyle W.,Garland Kyle M.,Pagendarm Hayden M.,Stone Payton T.,Arora Karan,Wang-Bishop Lihong,Baljon Jessalyn J.,Cruz Lorena D.,Joyce Sebastian,Wilson John T.

Funder

US Department of Veterans Affairs

National Science Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference81 articles.

1. Cancer vaccines: steering T cells down the right path to eradicate tumors;Ott;Cancer Discov.,2019

2. The human vaccines project: a roadmap for cancer vaccine development;Romero;Sci. Transl. Med.,2016

3. Personalized vaccines for cancer immunotherapy;Sahin;Science,2018

4. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines;Blass;Nat. Rev. Clin. Oncol.,2021

5. Breakthrough concepts in immune-oncology: cancer vaccines at the bedside;Roy;J. Leukoc. Biol.,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarrier design for pathogen-inspired innate immune agonist delivery;Trends in Immunology;2024-09

2. Boosting antigen-specific T cell activation with lipid-stabilized protein nanoaggregates;International Journal of Pharmaceutics;2024-08

3. Engineering customized nanovaccines for enhanced cancer immunotherapy;Bioactive Materials;2024-06

4. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine;Journal of Controlled Release;2024-05

5. Nanovaccines: An effective therapeutic approach for cancer therapy;Biomedicine & Pharmacotherapy;2024-01